Alpha Cognition Inc. Common Stock (ACOG) Fair Value 2026

ACOG · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.3 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-08-27, Alpha Cognition Inc. Common Stock (ACOG) trades at $9.73. QOC: 5.3/10. Value Trap Risk: 25/100 (LOW). 0/13 models active.

Key Facts

Ticker
ACOG
Price
$9.73
Quality Score
5.3/10
Value Trap Risk
25/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give ACOG?

0 Intrinsic Value Models vs. Current Price ($9.73)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Alpha Cognition Inc. Common Stock (ACOG) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Alpha Cognition Inc. Common Stock currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About ACOG?

0 of 13 models are currently active for ACOG. See which stocks rank higher →

How Does ACOG Rank in Biotechnology?

Among 620 Biotechnology stocks, ACOG ranks #249 by Quality of Company score. CirclFi's QOC score of 5.3/10 evaluates 32 fundamental signals. A score of 5.3 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

The Biotechnology sector introduces analytical considerations specific to biotech businesses. For Alpha Cognition Inc. Common Stock, metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is ACOG a Value Trap?

CirclFi's Value Trap algorithm assigns ACOG a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Alpha Cognition Inc. Common Stock. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Alpha Cognition Inc. Common Stock scores 5.3 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ACOG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Alpha Cognition Inc. Common Stock Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

NBTXNanobiotix S.A.QOC 5.3APGEApogee Therapeutics, Inc.QOC 5.3APLMApollomics, Inc.QOC 5.3PLURPluri Inc.QOC 5.3VSTMVerastem, Inc.QOC 5.4ICUSeaStar Medical Holding CorporationQOC 5.3VIVSVivoSim Labs, Inc.QOC 4.7RNAAtrium Therapeutics, Inc.QOC 3.7DYAIDyadic International, Inc.QOC 6.5EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: NBTX · APGE · APLM · PLUR · VSTM · ICU · VIVS · RNA · DYAI · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to ACOG?

7 companies across all industries closest to ACOG’s Quality of Company score of 5.3/10.

PMAXPowell Max LimitedQOC 5.3QSJCTancheng Group Co., Ltd.QOC 5.3HMHHMH Holding Inc.QOC 5.3HRGNHarvard Apparatus Regenerative Technology Inc.QOC 5.3BRWCBirdie Win CorporationQOC 5.3NUAINew Era Energy & Digital, Inc.QOC 5.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PMAX · QSJC · HMH · HRGN · BRWC · NUAI · NVDA

Where Does ACOG Sit in CirclFi's Biotechnology Rankings?

ACOG is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About Alpha Cognition Inc. Common Stock’s Valuation?

What is Alpha Cognition Inc. Common Stock's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Alpha Cognition Inc. Common Stock (ACOG). The Quality of Company score is 5.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ACOG overvalued or undervalued right now?

At $9.73, 0 of 0 active models suggest ACOG may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Alpha Cognition Inc. Common Stock's business model in Biotechnology.

What does a Quality of Company score of 5.3 mean for ACOG?

Alpha Cognition Inc. Common Stock's QOC of 5.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ACOG?

CirclFi analyzes ACOG with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is ACOG a value trap in 2026?

Alpha Cognition Inc. Common Stock's Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Alpha Cognition Inc. Common Stock (ACOG) a Quality of Company score of 5.3/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/ACOG/ · Methodology
Primary sources for this ACOG valuation
  • Financial statements: Alpha Cognition Inc. Common Stock 10-K and 10-Q filings on SEC EDGAR (CIK 0001655923) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ACOG as of ; valuations recomputed .